The approval represents a significant moment in the treatment of structural heart disease. Edwards will share updated data on the device at TCT 2023 in San Francisco.  

The company hopes this new round of funding from private-equity investors will help its home-based care model flourish and reach more patients than ever before. 

The doctor says the social media post that led to his suspension was taken out of context. "I have not supported, do not support and will not support acts of terrorism," he said. 

GE Healthcare's newest cardiac angiography offering will be on display at TCT 2023 in San Francisco. 

A group of interventional cardiologists, neurologists and vascular surgeons successfully petitioned Medicare to change its coverage determination for carotid stenting procedures.

Interventional cardiologist Alfred G. Valles, MD, was 50 years old at the time of the accident. According to colleagues, he "strived daily to achieve his vision for world-class care."

Even as TAVR continues to build momentum as the go-to treatment option for many patients, researchers are keeping a close eye on the long-term safety and effectiveness of SAVR.

The advanced algorithm achieved a sensitivity of 93% and specificity of 98%. It was trained to identify up to five different valvular diseases at the same time from a single audio clip.

The subcutaneous administration of CBD could make a significant impact on patient outcomes, according to new findings presented at the Heart Failure Society of America's annual meeting in Cleveland.

What does it take to scale the technology from a toe in the water to a full-on swim? 

The preliminary award includes $134M in underpayment damages, $9M in prejudgment interest, and $2.2M in attorney fees, arbitrators confirmed.